To catch up on part one of your guide to FlyPharma 2016, please click here
After the dust has settled from the previous evening, day two of the FlyPharma Conference 2016 offers an excellent opportunity to gain more insights into how collaboration is shaking up conventional pharmaceutical supply chains (for the better!), the practical routes to ensuring regulatory compliance and much more.
With plenty of more opportunities for networking and dialogue, as well coffee and lunch served, day two of FlyPharma ticks all the boxes. Here’s what your guide to FlyPharma day two:
Collaboration: It may be a running theme throughout the whole conference, but it is day two where FlyPharma really gets its mutually beneficial partnership cap on. The morning begins with some opening remarks and a presentation from Mark Blanchard, from the BioPhorum Operations Group, on a how a collaborative approach is shaking up biotech innovation, knowledge transfer and operational best practice.
He is followed by Hugh Williams, from Hughenden Consulting, on the best approaches to take on collaboration and how we can undo some of our misconceptions on the topic within the industry. Fast forward past the tea break, and we close our collaboration focus with a roundtable discussion on the issue of trust in pharma collaborations. With participants from Pfizer, Brussels Airport and Cargolux all included in the debate, this is bound to be a lively and engaging discussion.
Innovations: Another key focus of day two is innovative new solutions within pharmaceutical logistics. Therese Puetz, at Karavan Management Consulting, takes a morning session on innovation, investment and new ways of working that are transforming pharma air logistics.
To open the afternoon session, Malik Zeniti, from Cluster for Logistics, takes on a big challenge, but also a vital opportunity for our time: lean and green solutions in pharmaceutical logistics.
Practical solutions: Some of the most pressing issues within the pharmaceutical supply chain may be ever-present, but the shifting nature of these issues means that companies need to remain aware of trends in these common issues.
To that end, Mark Edwards, from Modalis, takes to the stage to talk about the practical steps towards compliance in route qualification. Towards the close of the day, we then have Edwin Visser, from CSafe Global, on lifecycle logistics in pharma. He identifies the growing need for shippers to balance capital costs with support, maintenance and readiness costs, and points the way forward.
FlyPharma 2016 is then closed by Hugh Williams who will deliver the closing keynote.
We truly hope you have a wonderful FlyPharma 2016. We are confident that one of pharma’s most innovative conference is sure to become an annual date for your diary. To take part in the conversation at the event, be sure to tweet using the hashtags #FlyPharma.